RxDoctor Payments Data

Eugene Giddens, MD

Neurological Surgery · Myrtle Beach, SCNPI 1932168986

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (47.1%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. Globus Medical accounts for 98.7% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $16,334 and has fallen 66.4% since, to $5,484 in 2025. Among neurological surgery clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$48,105in general payments, 2019–2025

Across 96 payments — averaging $501.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$47K
  • Boston Scientific$420
  • Irras USA, Inc.$125
  • Abbott$35
  • Surgalign Spine Technologies, Inc.$26
  • Novartis$20
  • plus $17 from 1 others

What the payments were for

  • Royalty or licence$22,63547%
  • Consulting fees$8,30017%
  • Speaking & faculty fees$8,00017%
  • Travel & lodging$7,37815%
  • Food & beverage$1,7924%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$48,105 in reported general payments places this provider in the 90th percentile of 114 neurological surgery providers in South Carolina.

See all neurological surgery providers in South Carolina

Medicare billing

Part B allowed, 2024
$372,641
Medicare patients
522
Services billed
1,411

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin34$340
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen17$156
Meloxicam26$153
Cyclobenzaprine Hcl22$118
Pregabalin12$112

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Myrtle Beach

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →